Literature DB >> 8389594

The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor.

I Issemann1, R A Prince, J D Tugwood, S Green.   

Abstract

The peroxisome proliferator activated receptor (PPAR) is a member of the steroid hormone receptor superfamily and is activated by a variety of non-genotoxic rodent hepatocarcinogens termed peroxisome proliferators. A key marker of peroxisome proliferator action is the peroxisomal enzyme acyl-CoA oxidase that is elevated about 10-fold in the liver of treated rodents. We have shown previously that a peroxisome proliferator response element (PPRE) is located 570 bp upstream of the rat acyl-CoA oxidase gene and that PPAR binds to it. We show here that the retinoid X receptor (RXR) is required for PPAR to bind to the PPRE and that the RXR ligand, 9-cis retinoic acid, enhances PPAR action. These results therefore suggest that retinoids may modulate the action of peroxisome proliferators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389594     DOI: 10.1016/0300-9084(93)90084-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  20 in total

1.  PPARgamma-regulated tight junction development during human urothelial cytodifferentiation.

Authors:  Claire L Varley; Mary A E Garthwaite; William Cross; Jennifer Hinley; Ludwik K Trejdosiewicz; Jennifer Southgate
Journal:  J Cell Physiol       Date:  2006-08       Impact factor: 6.384

Review 2.  Human nuclear receptor heterodimers: opportunities for detecting targets of transcriptional regulation using yeast.

Authors:  T R Butt; P G Walfish
Journal:  Gene Expr       Date:  1996

3.  Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.

Authors:  Denis A Mogilenko; Igor V Kudriavtsev; Vladimir S Shavva; Ella B Dizhe; Ekaterina G Vilenskaya; Alexander M Efremov; Andrej P Perevozchikov; Sergey V Orlov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

Review 4.  Biochemistry of peroxisomes in health and disease.

Authors:  I Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

5.  Dual DNA-binding specificity of peroxisome-proliferator-activated receptor gamma controlled by heterodimer formation with retinoid X receptor alpha.

Authors:  M Okuno; E Arimoto; Y Ikenobu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

6.  Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.

Authors:  Cigir Biray Avci; Yavuz Dodurga; Gulsah Gundogdu; Hasan Onur Caglar; Vural Kucukatay; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Tumour Biol       Date:  2013-07-03

7.  Differential alterations of ethanolamine and choline phosphoglyceride metabolism by clofibrate and retinoic acid in human fibroblasts are not mediated by phorbol ester-sensitive protein kinase C.

Authors:  S G Mandla; D M Byers; N D Ridgway; H W Cook
Journal:  Lipids       Date:  1996-07       Impact factor: 1.880

8.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

9.  Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.

Authors:  Tatiana M Garcia-Bates; Carolyn J Baglole; Matthew P Bernard; Thomas I Murant; Patricia J Simpson-Haidaris; Richard P Phipps
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription.

Authors:  T C Aldridge; J D Tugwood; S Green
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.